Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
A Phase 2A Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients with Acute Liver Failure/Severe Acute Liver Injury (STOP-ALF)
Grant
Overview
Affiliation
Overview
Awarded By
University of Texas Southwestern Medical Center at Dallas
Total Award Amount
20354.00
Direct Costs
13846.00
Sponsor Award Id
161118-STOP ALF
Affiliation
Contributor
Adam L. Edwards
Investigator
Brendan McGuire
Principal Investigator
Jenni Wise
Investigator
Mohamed Shoreibah
Investigator